tiprankstipranks
Advertisement
Advertisement

BLRX Stock Latest News

BioLineRx, Hemispherian initiate clinical trial of GLIX1
The FlyBioLineRx, Hemispherian initiate clinical trial of GLIX1
10d ago
BLRX
BioLineRx: Advancing GLIX1 and Motixafortide Pipeline with Strengthened IP and Legal Position Underpinning Buy Rating and $12 Target
PremiumRatings
BioLineRx: Advancing GLIX1 and Motixafortide Pipeline with Strengthened IP and Legal Position Underpinning Buy Rating and $12 Target
22d ago
BLRX
BioLineRx Launches First-in-Human Trial of GLIX1 for Glioblastoma
PremiumCompany Announcements
BioLineRx Launches First-in-Human Trial of GLIX1 for Glioblastoma
23d ago
6K
BLRX
BioLineRx initiates Phase 1/2a study of GLIX1
PremiumThe Fly
BioLineRx initiates Phase 1/2a study of GLIX1
23d ago
BLRX
Options Volatility and Implied Earnings Moves Today, March 23, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 23, 2026
26d ago
LAR
MBX
Options Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
PremiumMarket NewsOptions Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
26d ago
AIR
CCL
BioLineRx Sets March Start for GLIX1 Brain Cancer Trial as 2025 Results Show Leaner R&D-Focused Model
Premium
Company Announcements
BioLineRx Sets March Start for GLIX1 Brain Cancer Trial as 2025 Results Show Leaner R&D-Focused Model
26d ago
6K
BLRX
BioLineRx provides corporate update
Premium
The Fly
BioLineRx provides corporate update
26d ago
BLRX
Bioline RX Ltd Sponsored ADR (BLRX) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Bioline RX Ltd Sponsored ADR (BLRX) Q4 Earnings Cheat Sheet
1M ago
BLRX
BioLineRx Wins Arbitration Ruling in Motixafortide Licensing Dispute
PremiumCompany Announcements
BioLineRx Wins Arbitration Ruling in Motixafortide Licensing Dispute
2M ago
6K
BLRX
BioLineRx Earnings Call: Strategic Initiatives Amid Revenue Challenges
PremiumCompany Announcements
BioLineRx Earnings Call: Strategic Initiatives Amid Revenue Challenges
5M ago
BLRX
BioLineRx Reports Q3 2025 Results and Strategic Expansion
PremiumCompany Announcements
BioLineRx Reports Q3 2025 Results and Strategic Expansion
5M ago
BLRX
BioLineRx Announces Q3 2025 Financial Results and New Joint Venture
PremiumCompany AnnouncementsBioLineRx Announces Q3 2025 Financial Results and New Joint Venture
5M ago
6K
BLRX
Morning Movers: Novo Nordisk sinks after Alzheimer’s disease study results
Premium
The Fly
Morning Movers: Novo Nordisk sinks after Alzheimer’s disease study results
5M ago
NVO
WRD
Options Volatility and Implied Earnings Moves Today, November 24, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves Today, November 24, 2025
5M ago
A
LX
BioLineRx reports Q3 EPS 0c vs 0c last year
PremiumThe Fly
BioLineRx reports Q3 EPS 0c vs 0c last year
5M ago
BLRX
Options Volatility and Implied Earnings Moves This Week, November 24 – November 26, 2025
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, November 24 – November 26, 2025
5M ago
A
DE
BLRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
BLRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
BLRX
BioLineRx Secures USPTO Patent Allowance for Cancer Treatment with GLIX1
PremiumCompany Announcements
BioLineRx Secures USPTO Patent Allowance for Cancer Treatment with GLIX1
5M ago
6K
BLRX
BioLineRx and Hemispherian Launch Joint Venture to Develop GLIX1 for Glioblastoma
PremiumCompany AnnouncementsBioLineRx and Hemispherian Launch Joint Venture to Develop GLIX1 for Glioblastoma
7M ago
6K
BLRX
BioLineRx, Hemispherian AS establish joint venture to develop GLIX1
Premium
The Fly
BioLineRx, Hemispherian AS establish joint venture to develop GLIX1
7M ago
BLRX
BioLineRx ADR Earnings Call: Optimism Amid Challenges
Premium
Company Announcements
BioLineRx ADR Earnings Call: Optimism Amid Challenges
8M ago
BLRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >